Get the latest crypto news, updates, and reports by subscribing to our free newsletter.
Giấy phép số 4978/GP-TTĐT do Sở Thông tin và Truyền thông Hà Nội cấp ngày 14 tháng 10 năm 2019 / Giấy phép SĐ, BS GP ICP số 2107/GP-TTĐT do Sở TTTT Hà Nội cấp ngày 13/7/2022.
© 2026 Index.vn
Organogenesis Holdings Inc. (Nasdaq: ORGO) said it will report its first-quarter fiscal year 2026 financial results after the market closes on Thursday, May 7.
Management will host a conference call at 5:00 p.m. Eastern Time on May 7 to discuss the quarter’s results and provide a corporate update, followed by a question-and-answer session.
The company said participants can access the live webcast and the teleconference via links provided with the announcement. The live webcast is also available on the company’s website at investors.organogenesis.com. The webcast will be archived on the website for approximately one year.
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture, and commercialization of products for the advanced wound care and surgical and sports medicine markets.
The company offers a portfolio of regenerative products designed to address patient needs across the continuum of care.

Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…